Journal of Nutrition LabDiet, Your World of Nutritional Answers

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Juan, M. E.
Right arrow Articles by Planas, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Juan, M. E.
Right arrow Articles by Planas, J. M.
© 2002 The American Society for Nutritional Sciences J. Nutr. 132:257-260, 2002


Research Communication

The Daily Oral Administration of High Doses of trans-Resveratrol to Rats for 28 Days Is Not Harmful1

M. Emília Juan, M. Pilar Vinardell and Joana M. Planas2

Departament de Fisiologia–Divisió IV, Facultat de Farmàcia, Universitat de Barcelona, E-08028 Barcelona, Spain

2To whom correspondence and reprint requests should be addressed. E-mail: jplanas{at}farmacia.far.ub.es.

trans-3,5,4'-Trihydroxystilbene (trans-resveratrol) is a phytochemical present in peanuts, grapes and wine with beneficial effects such as protection against cardiovascular disease and cancer prevention. The purpose of this study was to evaluate whether high doses of trans-resveratrol have harmful effects on Sprague-Dawley rats. trans-Resveratrol was administered orally to male rats for 28 d at a dose of 20 mg/(kg · d), 1000 times the amount consumed by a 70-kg person taking 1.4 g of trans-resveratrol/d. Body weight, and food and water consumption did not differ between rats treated with trans-resveratrol and the control group. Hematologic and biochemical variables were not affected by the treatment. Histopathologic examination of the organs obtained at autopsy did not reveal any alterations. These results support the view that repeated consumption of trans-resveratrol at 20 mg/(kg · d) does not adversely affect the variables tested in rats.


KEY WORDS: • trans-resveratrol • phytochemicals • polyphenols • rats




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
A. M. Roccaro, X. Leleu, A. Sacco, A.-S. Moreau, E. Hatjiharissi, X. Jia, L. Xu, B. Ciccarelli, C. J. Patterson, H. T. Ngo, et al.
Resveratrol Exerts Antiproliferative Activity and Induces Apoptosis in Waldenstrom's Macroglobulinemia
Clin. Cancer Res., March 15, 2008; 14(6): 1849 - 1858.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. W. E. Rush, J. Quadrilatero, A. S. Levy, and R. J. Ford
Chronic Resveratrol Enhances Endothelium-Dependent Relaxation but Does Not Alter eNOS Levels in Aorta of Spontaneously Hypertensive Rats
Experimental Biology and Medicine, June 1, 2007; 232(6): 814 - 822.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Sengottuvelan, P. Viswanathan, and N. Nalini
Chemopreventive effect of trans-resveratrol - a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis
Carcinogenesis, May 1, 2006; 27(5): 1038 - 1046.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Boissy, T. L. Andersen, B. M. Abdallah, M. Kassem, T. Plesner, and J.-M. Delaisse
Resveratrol Inhibits Myeloma Cell Growth, Prevents Osteoclast Formation, and Promotes Osteoblast Differentiation
Cancer Res., November 1, 2005; 65(21): 9943 - 9952.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Tyagi, R. P. Singh, C. Agarwal, S. Siriwardana, R. A. Sclafani, and R. Agarwal
Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells
Carcinogenesis, November 1, 2005; 26(11): 1978 - 1987.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Q. Zhang, X. Tang, Q. Y. Lu, Z. F. Zhang, J. Brown, and A. D. Le
Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1{alpha} and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells
Mol. Cancer Ther., October 1, 2005; 4(10): 1465 - 1474.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
H. Jiang, L. Zhang, J. Kuo, K. Kuo, S. C. Gautam, L. Groc, A. I. Rodriguez, D. Koubi, T. Jackson Hunter, G. B. Corcoran, et al.
Resveratrol-induced apoptotic death in human U251 glioma cells
Mol. Cancer Ther., April 1, 2005; 4(4): 554 - 561.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. E. Juan, E. Gonzalez-Pons, T. Munuera, J. Ballester, J. E. Rodriguez-Gil, and J. M. Planas
trans-Resveratrol, a Natural Antioxidant from Grapes, Increases Sperm Output in Healthy Rats
J. Nutr., April 1, 2005; 135(4): 757 - 760.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. A. Crowell, P. J. Korytko, R. L. Morrissey, T. D. Booth, and B. S. Levine
Resveratrol-Associated Renal Toxicity
Toxicol. Sci., December 1, 2004; 82(2): 614 - 619.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
J. Leiro, E. Cano, F. M. Ubeira, F. Orallo, and M. L. Sanmartin
In Vitro Effects of Resveratrol on the Viability and Infectivity of the Microsporidian Encephalitozoon cuniculi
Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2497 - 2501.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. R. Stewart, M. C. Artime, and C. A. O'Brian
Resveratrol: A Candidate Nutritional Substance for Prostate Cancer Prevention
J. Nutr., July 1, 2003; 133(7): 2440S - 2443.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2002 by American Society for Nutrition